lodoxamide has been researched along with amlexanox in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Fang, Y; Hou, T; Li, J; Liang, X; Qu, L; Shi, L; Wang, J; Wang, P; Wei, L; Zhang, X; Zhao, Y | 1 |
2 other study(ies) available for lodoxamide and amlexanox
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Discovery of 2H-Chromen-2-one Derivatives as G Protein-Coupled Receptor-35 Agonists.
Topics: Benzopyrans; Carbon-13 Magnetic Resonance Spectroscopy; HT29 Cells; Humans; Mass Spectrometry; Proton Magnetic Resonance Spectroscopy; Receptors, G-Protein-Coupled | 2017 |